Research

At InterveneRx, we want to keep you informed about the specialty drug industry.  Listed below are publications to help us do that:

 

13th Annual EMD Serono Specialty Digest™ Details Utilization and Clinical Management Trend
Yahoo News,May 1, 2017
https://finance.yahoo.com/news/13th-annual-emd-serono-specialty-162600037.html?soc_src=social-sh&soc_trk=tw 

 

FDA Approvals for Specialty Drugs to pick up in 2017
Modern Medicine Network, March, 29, 2017

http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/fda-approvals-specialty-drugs-pick-2017 

 

Annual Medical Pharmacy Trend Report Illustrated Impact of Costly Specialty Drugs
Specialty Pharmacy Times, April 4, 2017

https://www.specialtypharmacytimes.com/news/annual-medical-pharmacy-trend-report-illustrates-impact-of-costly-specialty-drugs 

 

Amgen’s PCSK9 inhibitor Repatha significantly cuts risk for cardiovascular events in outcomes study, but falls short of expectations.
First Word Pharma, March 21, 2017

https://www.firstwordpharma.com/node/1456919 

 

Harvard Pilgrim expands use of novel drug purchasing deals

Boston Globe, February 22, 2017; Priyanka Dayal McCluskey, Curt Woodward

https://www.bostonglobe.com/business/2017/02/21/harvard-pilgrim-expands-use-novel-drug-purchasing-deals/3wI4St0I37P6vpLLcocyrN/story.html 

 

Plan Sponsors Zero in on Specialty Rx Costs, Retail 90 Networks in 2017 Benefits

AISHealth January 17, 2017; Reprinted from Drug Benefit News, Volume 17 Issue 21 November 4, 2016

https://aishealth.com/archive/ndbn110416-02

 

Policy Recommendations to Promote Sustainable, Affordable Pricing for Specialty Pharmaceuticals, A National Business Group on Health Publiication, National Business Group on Health, Policy Brief, January 2017

https://www.businessgrouphealth.org/pub/C317670B-782B-CB6E-2763-670A3E8568A0

 

Archimedes Specialty Drug Forecast:  2016-2020

Archimedes, LLC. November 2016

http://archimedesrx.com/wp-content/uploads/2016/11/Archimedes-Specialty-Forecast-FINAL-Nov2016.pdf